
TY  - JOUR
TI  - Free Paper Abstracts
JO  - Anaesthesia
JA  - Anaesthesia
VL  - 69
IS  - s4
SN  - 0003-2409
UR  - https://doi.org/10.1111/anae.12866
DO  - doi:10.1111/anae.12866
SP  - 11
EP  - 88
PY  - 2014
ER  - 

TY  - JOUR
TI  - Swiss Society of Surgery
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 95
IS  - S2
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.6206
DO  - doi:10.1002/bjs.6206
SP  - 1
EP  - 26
PY  - 2008
AB  - Abstract The following abstracts were presented at the 95th Annual Congress of the Swiss Society of Surgery. The meeting, held in Basel 28?30 May 2008, is organized for the sixth time in collaboration with the Swiss Society of Thoracic, Heart and Vascular Surgery. To view the abstracts from this meeting, please click the pdf link on this page. Copyright ? 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - 2019 ACVIM Forum Research Abstract Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 33
IS  - 5
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.15597
DO  - doi:10.1111/jvim.15597
SP  - 2375
EP  - 2547
PY  - 2019
ER  - 

TY  - JOUR
TI  - Venice Arrhythmias 2011: October 9-12, 2011—Venice, Italy
JO  - Journal of Cardiovascular Electrophysiology
VL  - 22
IS  - s1
SN  - 1045-3873
UR  - https://doi.org/10.1111/j.1540-8167.2011.02154.x
DO  - doi:10.1111/j.1540-8167.2011.02154.x
SP  - S1
EP  - S172
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - HIV Medicine
JA  - HIV Med
VL  - 20
IS  - S5
SN  - 1464-2662
UR  - https://doi.org/10.1111/hiv.12739
DO  - doi:10.1111/hiv.12739
SP  - 16
EP  - 75
PY  - 2019
ER  - 

AU  - Mally, Angela
C7  - pp. 171-194
TI  - Biomarkers as Tools for Predictive Safety Assessment: Novel Markers of Drug-Induced Kidney Injury
SN  - 9783527336081
UR  - https://doi.org/10.1002/9783527674183.ch09
DO  - doi:10.1002/9783527674183.ch09
SP  - 171-194
KW  - biomarkers
KW  - blood urea nitrogen (BUN)
KW  - drug induced kidney injury
KW  - kidney injury molecule- 1 (KIM-1)
KW  - novel biomarkers
KW  - predictive toxicology
KW  - serum creatinine
PY  - 2019
AB  - Summary The paramount aim of predictive toxicology in drug discovery and development is to assess the safety of drugs for use in humans. This chapter presents drug induced kidney injury as an example to illustrate the value and limitations of novel biomarkers by providing an overview of their (patho) physiological role and mechanistic link to toxicity, performance in experimental toxicity studies, approval by regulatory bodies, and application to preclinical decision making. Traditional markers of renal function such as serum creatinine and blood urea nitrogen (BUN) are inherently insensitive as they indicate kidney injury only when large amounts of the renal epithelium have been lost. The most widely studied urinary kidney biomarker is kidney injury molecule- 1 (KIM-1) encoded by the gene Havr1 (hepatitis A virus cellular receptor 1). Advances in science and technology (e.g., microRNAs, next-generation sequencing) may also offer unique opportunities for the discovery of predictive biomarkers.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 122
IS  - S4
SN  - 9783527336081
UR  - https://doi.org/10.1111/1471-0528.13810
DO  - doi:10.1111/1471-0528.13810
SP  - 1
EP  - 63
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstract Supplement 2019 ACR/ARP Annual Meeting
JO  - Arthritis & Rheumatology
JA  - Arthritis Rheumatol
VL  - 71
IS  - S10
SN  - 9783527336081
UR  - https://doi.org/10.1002/art.41108
DO  - doi:10.1002/art.41108
SP  - 1
EP  - 5420
PY  - 2019
AB  - Abstract For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - E-Posters
JO  - Australian and New Zealand Journal of Obstetrics and Gynaecology
JA  - Aust N Z J Obstet Gynaecol
VL  - 59
IS  - S1
SN  - 9783527336081
UR  - https://doi.org/10.1111/ajo.13067
DO  - doi:10.1111/ajo.13067
SP  - 11
EP  - 82
PY  - 2019
ER  - 

AU  - Mishra, Narayan Chandra
AU  - Majumder, Sharmistha Mitra
C7  - pp. 197-225
TI  - Polymeric Nanofibers in Regenerative Medicine
SN  - 9781118414095
UR  - https://doi.org/10.1002/9781118636299.ch8
DO  - doi:10.1002/9781118636299.ch8
SP  - 197-225
KW  - Regenerative medicine
KW  - electrospinning
KW  - nanofibers
KW  - scaffold
KW  - tissue engineering
PY  - 2019
AB  - Summary This chapter contains sections titled: Introduction Preparation of Nanofibers Recent Advances on Application of Polymeric Nanofibers in Regenerative Medicine Conclusions
ER  - 

AU  - Curtis, Elizabeth
AU  - Sewry, Caroline
C7  - pp. 89-115
TI  - Electron Microscopy in Skeletal Muscle Pathology
SN  - 9781119973997
UR  - https://doi.org/10.1002/9781118452813.ch3
DO  - doi:10.1002/9781118452813.ch3
SP  - 89-115
KW  - EM in skeletal muscle pathology
KW  - TEM for sample normality/abnormality at LM level
KW  - pathological, understanding normal muscle variability
KW  - sarcolemma, changes in organelles
KW  - caveolae in normal myocyte, and signalling pathways
KW  - glycogen storage disease, particles in sarcoplasm/lysosomes
KW  - cores, degrees of myofibrillar disruption
KW  - MSS, myonuclei and electron-dense around nuclear envelope
KW  - autophagic vacuolar myopathies by AVSF, phenotypically diverse
KW  - structural defects, cylindrical spirals/fingerprint/cytoplasmic bodies
PY  - 2019
AB  - Summary This chapter contains sections titled: Introduction Normal Muscle Pathological Changes References
ER  - 

TY  - JOUR
TI  - 2018 Scientific Program
JO  - Journal of Ultrasound in Medicine
JA  - J Ultrasound Med
VL  - 37
IS  - S1
SN  - 9781119973997
UR  - https://doi.org/10.1002/jum.14750
DO  - doi:10.1002/jum.14750
SP  - S1
EP  - S220
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts—Posters
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Re
VL  - 43
IS  - S1
SN  - 9781119973997
UR  - https://doi.org/10.1111/acer.14059
DO  - doi:10.1111/acer.14059
SP  - 27A
EP  - 258A
PY  - 2019
ER  - 

TY  - JOUR
TI  - 2011 ACCP Annual Meeting
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 31
IS  - 10
SN  - 9781119973997
UR  - https://doi.org/10.1592/phco.31.10.311e
DO  - doi:10.1592/phco.31.10.311e
SP  - 311e
EP  - 453e
PY  - 2011
ER  - 

TY  - JOUR
AU  - Marcovina, S. M.
AU  - Crea, F.
AU  - Davignon, J.
AU  - Kaski, J. C.
AU  - Koenig, W.
AU  - Landmesser, U.
AU  - Pieri, P. L.
AU  - Schulz-Menger, J.
AU  - Shaw, L. J.
AU  - Sobesky, J.
TI  - Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools
JO  - Journal of Internal Medicine
VL  - 261
IS  - 3
SN  - 9781119973997
UR  - https://doi.org/10.1111/j.1365-2796.2006.01734.x
DO  - doi:10.1111/j.1365-2796.2006.01734.x
SP  - 214
EP  - 234
KW  - acute coronary syndrome
KW  - biochemical markers
KW  - bioimaging cardiovascular disease
KW  - congestive heart failure
KW  - stroke
PY  - 2007
AB  - Abstract. This report from the first International Course on Integrated Biomarkers, Biochemical and Bioimaging Endpoints in Cardiovascular Diagnosis, Prevention, Therapy and Drug Development provides the basis for optimizing diagnostic, prognostic and therapeutic information in four areas of cardiovascular medicine: primary prevention of cardiovascular diseases, acute coronary syndromes, heart failure and stroke. Risk stratification and treatment strategies can be refined and enhanced through integration of bioimaging and biochemical markers to characterize sub-clinical and clinical atherosclerosis. For the integrative approach to be useful, each of the biomarkers must be validated and cost-effective. Clinical decision is the primary level of integration and is based on clinical evaluation and the use of a combination of bioimaging and biochemical markers. The decision to initiate preventive or therapeutic intervention must take into account the factors affecting the levels of expression of the biomarker and the potential input the biomarker has on metabolic processes or modulation of other biomarkers. The optimal approach to intervention must take into consideration the risk?benefit and cost?effectiveness ratios.
ER  - 

TY  - JOUR
TI  - ESSR ABSTRACTS 2010
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S4
SN  - 9781119973997
UR  - https://doi.org/10.1002/bjs.7158
DO  - doi:10.1002/bjs.7158
SP  - S1
EP  - S58
PY  - 2010
AB  - Abstract The 45th Congress of the European Society for Surgical Research takes place this year in Geneva, Switzerland, 9?12 June 2010, under the presidency of Mustafa Cikirikcioglu, MD, PhD. Copyright ? 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

AU  - Mitra, Sumegha
AU  - Lloveras, Daniel Turner
AU  - Ma, Shwu-Fan
AU  - Garcia, Joe G. N.
C7  - pp. 399-415
TI  - Genetic Insights into Endothelial Barrier Regulation in the Acutely Inflamed Lung
SN  - 9780470723616
UR  - https://doi.org/10.1002/9780470747490.ch24
DO  - doi:10.1002/9780470747490.ch24
SP  - 399-415
KW  - endothelial barrier regulation in acutely inflamed lung and genetic insights
KW  - Acute lung injury (ALI) - devastating syndrome of diffuse alveolar damage
KW  - vascular barrier regulatory cytokines
KW  - CXCR4 gene - novel candidate gene for ALI
KW  - c-Met (HGF)
KW  - HGF and tyrosine kinase receptor, c-Met role in lung development
KW  - mechanosensitive genes with endothelial barrier-regulatory effects
KW  - GADD45α - small 18-kDa nuclear protein
KW  - ALI, enigmatic syndrome and insights into ALI pathobiology
PY  - 2010
AB  - Summary This chapter contains sections titled: Introduction Vascular Barrier Regulatory Cytokines, Growth Factors, and Mediators Receptors for Barrier-Regulatory Agonists Endothelial Cytoskeletal Protein Targets with Barrier-Regulatory Properties Mechanosensitive Genes with Endothelial Barrier-Regulatory Effects References
ER  - 

TY  - JOUR
TI  - Paper Abstracts
JO  - Journal of the American Geriatrics Society
VL  - 58
IS  - s1
SN  - 9780470723616
UR  - https://doi.org/10.1111/j.1532-5415.2010.02850.x
DO  - doi:10.1111/j.1532-5415.2010.02850.x
SP  - 1
EP  - 246
PY  - 2010
ER  - 

TY  - JOUR
TI  - Paper Session Ethics & Quality of Life
JO  - Journal of the American Geriatrics Society
VL  - 56
IS  - s1
SN  - 9780470723616
UR  - https://doi.org/10.1111/j.1532-5415.2007.01743.x
DO  - doi:10.1111/j.1532-5415.2007.01743.x
SP  - 1
EP  - 211
PY  - 2008
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 48
IS  - s2
SN  - 9780470723616
UR  - https://doi.org/10.1111/j.1537-2995.2008.01891.x
DO  - doi:10.1111/j.1537-2995.2008.01891.x
SP  - 1A
EP  - 241A
PY  - 2008
ER  - 
